首页    期刊浏览 2024年10月05日 星期六
登录注册

文章基本信息

  • 标题:Central pontine myelinolysis during treatment of hyperglycemic hyperosmolar syndrome: a case report
  • 其他标题:Central pontine myelinolysis during treatment of hyperglycemic hyperosmolar syndrome: a case report
  • 本地全文:下载
  • 作者:Koshi Kusumoto ; Nobuyuki Koriyama ; Nami Kojima
  • 期刊名称:Clinical Diabetes and Endocrinology
  • 印刷版ISSN:2055-8260
  • 出版年度:2020
  • 卷号:6
  • 期号:1
  • 页码:1-6
  • DOI:10.1186/s40842-020-00111-6
  • 出版社:BioMed Central
  • 摘要:Central pontine myelinolysis (CPM) is a non-inflammatory demyelinating lesion of the pons. CPM and extrapontine demyelination (EPM) are together termed osmotic demyelination syndrome (ODS), a known and serious complication of acute correction of hyponatremia. Conversely, hyperglycemic hyperosmolarity syndrome (HHS) develops in patients with type 2 diabetes who still have some insulin secretory ability due to infection, non-compliance with treatment, drugs, and coexisting diseases, and is often accompanied by ketosis. HHS represents a life-threatening endocrine emergency (mortality rate, 10–50%) associated with marked hyperglycemia and severe dehydration. HHS may develop ODS, and some cases have been associated with hypernatremia. The patient was an 87-year-old woman with hyperglycemia, dehydration, malnutrition, and potential thrombus formation during long-term bed rest. HHS was suspected to have developed due to progression of hyperglycemia and dehydration caused by pneumonia. Furthermore, ketoacidosis developed from ketosis and prerenal renal failure associated with circulating hypovolemia shock, which was also associated with disseminated intravascular coagulation. Treatment was started with continuous intravenous injection of fast-acting insulin and low-sodium replacement fluid. In addition, ceftriaxone sodium hydrate, heparin sodium, thrombomodulin α, human serum albumin, and dopamine hydrochloride were administered. Blood glucose, serum sodium, serum osmolality, and general condition (including vital, infection/inflammatory findings, and disseminated intravascular coagulation) improved promptly, but improvements in disturbance of consciousness were poor. Diffusion-weighted imaging of the brain 72 h after starting treatment showed no obvious abnormalities, but high-intensity signals in the midline of the pons became apparent 30 days later, leading to definitive diagnosis of CPM. Fluctuation of osmotic pressure by treatment from hyperosmolarity due to hyperglycemia and hypernatremia in the presence of risk factors such as malnutrition, severe illness, and metabolic disorders may be a cause of CPM onset. When treating HHS with risk factors, the possibility of progression to ODS needs to be kept in mind.
  • 关键词:Central pontine myelinolysis ; Osmotic demyelination syndrome ; Hyperglycemic hyperosmolarity syndrome ; Hypernatremia ; Diffusion-weighted imaging
国家哲学社会科学文献中心版权所有